 |
|
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park
Clin Mol Hepatol. 2013;19(2):148-155. Published online 2013 Jun 27 DOI: https://doi.org/10.3350/cmh.2013.19.2.148
|
|
Citations to this article as recorded by
 Thrombocytopenia in Virus Infections
Matthijs Raadsen, Justin Du Toit, Thomas Langerak, Bas van Bussel, Eric van Gorp, Marco Goeijenbier
Journal of Clinical Medicine.2021; 10(4): 877. CrossRef Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment
Sun Hee Lee, Hyun Phil Shin, Joung Il Lee
Antiviral Chemistry and Chemotherapy.2020; 28: 204020662097483. CrossRef
|